Investor Package Preparation

This package outlines the financial structure and market potential to help investors make informed decisions. We develop a comprehensive package that includes a business plan, feasibility study, and..

Business Structuring

Our business plan (BP) is a powerful tool for attracting investors, as it outlines the project’s objectives, strategies, financial projections, and market potential. This is further enhanced by a robust feasibility study (FS), which assesses the project’s technical, economic, and operational viability. In addition, we define a business model (BM) that details revenue generation and cost structures and how the product will be strategically positioned in the market.

Securing Funding

We then provide an actionable roadmap through an action plan (AP), breaking down milestones and deliverables to keep the project on track. To effectively communicate the investment opportunity, we design a professional pitch deck, highlighting key selling points for potential backers. Additionally, we prepare a detailed investment memorandum (IM), which serves as a legal and financial document outlining risks, returns, and the overall investment structure.

Let Us Support Your Product's Success

SartoMax is committed to accelerating the future of biopharmaceutical development. Contact us to explore more how our CDMO solutions can support your biomanufacturing goals.

Related Products

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Related Assets

Frequently Asked Questions

Our investor package includes documents such as Business Plan (BP), Feasibility Study (FS), Business Model (BM), Action Plan (AP), and Pitch Deck—all tailored to showcase your project’s value and attract serious investors.
Whether you’re seeking seed funding or later-stage investment, we provide the documents to match investors’ expectations at each stage.
We follow best practices used in global biotech funding circles, while incorporating UAE-specific regulatory and market considerations. This ensures your investor package is not only locally competitive but also aligns with international standards, reassuring you about the quality of our service.
As a CDMO based in Dubai, we combine regional market insight with international expertise. Our unique position allows us to understand investor expectations in the Middle East and global biotech sectors, giving your project a competitive edge.

Consult Our Experts

Related Articles

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Related Courses

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.